Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS South Australia Inc
 
 
Facebook
 
ME/CFS SOUTH AUSTRALIA INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:

PO Box 322,
Modbury North,
South Australia 5092

Phone:
1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm
(phone)

ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
DOCX Application Form (Word, 198 KB)
Why become a member?

Immune-Modulating Agents Eyed For Chronic Fatigue Syndrome

Sunday 13 November 2016

 

From Medscape:

 

Medscape
 

Immune-Modulating Agents Eyed for 'Chronic Fatigue Syndrome'

By Miriam E. Tucker
November 11, 2016
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.

Fort Lauderdale, FL — The illness known as "chronic fatigue syndrome" isn't typically considered within the purview of oncology, but a chance finding in 2004 led two Norwegian oncologists on a career-consuming mission to shed light on the controversial condition.

...

In 2004, oncologists Øystein Fluge, MD, and Olav Mella, MD, PhD, both at Haukeland University Hospital, University of Bergen in Norway, were treating a patient with lymphoma who also had long-standing ME/CFS. When they gave her cytotoxic chemotherapy, including the B cell–depleting monoclonal antibody rituximab, her ME/CFS symptoms improved.

 

Full article…

 


 

blog comments powered by Disqus
Previous Previous Page